Search the GHTC website
November 16, 2026

Closing the gaps in cervical cancer prevention and treatment through innovation

Twenty years after the approval of the first HPV vaccine, a game-changing tool that has helped dramatically reduce rates of HPV infection and cervical cancer around the world, researchers are now developing new tools to address remaining gaps in cervical cancer screening, diagnosis, and care.

November 2, 2026

Research Roundup: Nipah and Hendra viruses diagnostic, Bundibugyo vaccine candidate, Hepatitis C vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

October 5, 2026

Research Roundup: Pooled TB testing, Promising antimalarial, Antifungal development funding

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

September 11, 2026

Fungal diseases are rising. Innovation must keep up.

Fungal diseases are a growing global health threat, driven in part by the rise in antifungal resistance. A persistent lack of attention and investment has fueled gaps in innovation, but several promising treatments and diagnostic tools demonstrate the potential for R&D to transform the global response.